Volume 7 Issue 1, Jan 2022

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 7 Issue 1, Jan 2022:
Research Highlight
First-line anti-VEGF plus EGFR-TKI in EGFR-mutant NSCLC: adding the ARTEMIS trial to the puzzle of current evidence
Susanne Hafner  ORCID: orcid.org/0000-0003-0663-8382